Skip to content
HOME
TEAM
RESEARCH
Unveiling the role of gut microbiota and microbial metabolites in MASLD pathogenesis
Gut microbiota and MASH/fibrosis resolution after bariatric surgery
Evaluation of the epigenome, microbiome, and metabolome dynamics and their interaction with the adiposity increase in the maternal-infant axis
Epitranscriptomic analysis in patients with MASLD/MASH: exploring diagnostic and therapeutic potential
Role of small intestine in type 2 diabetes mellitus and search for new therapeutic strategies
PROJECTS
PUBLICATIONS
NEWS
CONTACT
Loading...
RESEARCH
RESEARCH
MetaObesity Lab
2021-09-10T19:09:34+02:00
Research Lines
OUR LABORATORY IS CURRENTLY WORKING ON 3 MAIN ACTIVE RESEARCH LINES.
Unveiling the role of gut microbiota and epigenetic alterations in the pathogenesis of non-alcoholic fatty liver disease (NAFLD)
Gut microbiota and related metabolites as potential markers of non-alcoholic steatohepatitis (NASH) resolution after bariatric surgery
Gut microbiome modification through dietary intervention in patients with colorectal cancer (CRC) and response to surgery
Page load link
Go to Top